Dr. Timothy William Burke, D.O. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 15775 Se 82nd Dr, Clackamas, OR 97015 Phone: 503-722-9155 Fax: 503-722-0420 |
David D Clarke, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 9900 S.e. Sunnyside Rd., Clackamas, OR 97015 Phone: 503-571-8240 |
Dr. Elaine Rose Gossman, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 9900 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-571-8240 |
Dr. Caroline R. Tadros, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: Kaiser Permanente Sunnybrook Medical Offices, 9900 Se Sunnyside Rd., Clackamas, OR 97015 Phone: 503-652-2880 |
Dr. Jeffrey Stephen Olson, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9900 Se Sunnyside Road, Kaiser Sunnybrook Medical Office, Clackamas, OR 97015 Phone: 503-571-9134 Fax: 503-571-3069 |
News Archive
Researchers at the Institute for Genome Sciences at the University of Maryland School of Medicine and collaborators at the FBI, the U.S. Army Medical Research Institute of Infectious Diseases and Northern Arizona University have published the first scientific paper based on their investigation into the anthrax attacks of 2001.
Two-thirds of patients stopped using Uprima, a drug commonly prescribed for erection problems, because they felt it wasn't effective, according to a large-scale study published in the July issue of the urology journal BJU International.
Liberator Medical Holdings, Inc. announced net revenues for fiscal year 2009 of $25,818,000, representing an increase of $16,268,000, or 170.3%, compared with fiscal year 2008. The increase in sales occurred in the mail order segment of its business. The increase was due to a substantial direct-response advertising campaign to obtain new mail order customers.
A international team led by scientists from the Genomics Institute of the Novartis Research Foundation (GNF) and The Scripps Research Institute has discovered a family of chemical compounds that could lead to a new generation of antimalarial drugs capable of not only alleviating symptoms but also preventing the deadly disease.
› Verified 9 days ago